Impact of Virtual Reality on Anxiety in Patients Undergoing Interventional Procedures
NCT05744336
Summary
Periprocedural anxiety is a common problem for patients who undergo interventional pain procedures. Virtual Reality (VR) is an immersive experience that has gained acceptance in the medical field as a tool for reducing anxiety and pain for patients.Research Aim: To evaluate the effect of immersive virtual reality (VR) on periprocedural anxiety related to therapeutic cervical epidural steroid injections (ESI). The investigators hypothesize that immersive virtual reality will result in a clinically meaningful anxiety reduction, defined as the proportion of participants with \> 50% reduction in Numeric Rating Scale (NRS) anxiety scores when compared to participants in the non-treatment group who will have standard preprocedural waiting time conditions in clinic, but no VR experience. Similarly, the investigators hypothesize a significant reduction in objective sympathetic tone as measured by skin sympathetic nerve activity (SKNA).
Eligibility
Inclusion Criteria: * Age 18-80 years old at day of enrollment * Neck pain patient deemed to be a candidate for pain control treatment with interventional fluoroscopically guided cervical epidural steroid injection as determined by their pain medicine provider based on history, physical exam, and radiographic findings * Willingness to undergo pre-procedural intervention of VR viewing experience or equivalent pre-procedural wait time * No history of prior epidural steroid injections * Did not receive sedatives prior to or during procedure Exclusion Criteria: * Refusal / inability to participate or provide consent * Contraindications to injection (anticoagulated states, allergy to components of injection, local infection at injection site, current infectious process or treatment of antibiotics for current infection) * Uncontrolled anxiety disorder or untreated/inadequately treated psychiatric disorder * History of Alzheimer's, dementia, or cognitive dysfunction * Patient currently taking benzodiazepines * Severe motion sickness * Seizure disorder * Vision loss * Non-English speaking patients
Conditions1
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05744336